Cited by 479

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

The Mitochondrial-Targeted Compound SS-31 Re-Energizes Ischemic Mitochondria by Interacting with Cardiolipin

Birk, Alexander V., Liu, Shaoyi, Soong, Yi, Mills, William, Singh, Pradeep, Warren, J. David, Seshan, Surya V., Pardee, Joel D., Szeto, Hazel H.·2013·Journal of the American Society of Nephrology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1681/asn.2012121216

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Compounds currently in clinical trials for mitochondrial disease are predominantly antioxidants (such as Idebenone, EPI-743 and RPI-103) and small molecules that stabilize organelle membrane architecture (Elampritide/SS31).

    “Compounds currently in clinical trials are predominantly antioxidants (such as Idebenone, EPI-743 and RPI-103) and small molecules that have the capability of stabilizing the organelle membrane architecture (Elampritide/SS31) [178].”

    From The Mitochondrial Genome in Aging and Disease and the Future of Mitochondrial Therapeutics (2022) · cites this paper as [178]

    The Discussion (page not provided) reports that SS-31 preserved mitochondrial cristae membranes and prevented swelling in rats with renal ischemia, supporting the membrane-stabilization part of the claim. Our copy does not support the broader assertion that clinical-trial compounds are predominantly antioxidants, identify Idebenone, EPI-743 or RPI-103 as trial compounds, or establish trials for mitochondrial disease. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 51

  1. Bagshaw, 2005, Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: A population-based study., Crit Care, 9, R700, 10.1186/cc3879 · DOI
  2. Bon, 2012, New strategies to optimize kidney recovery and preservation in transplantation., Nat Rev Nephrol, 8, 339, 10.1038/nrneph.2012.83 · DOI
  3. Chapman, 2005, Chronic renal allograft dysfunction., J Am Soc Nephrol, 16, 3015, 10.1681/ASN.2005050463 · DOI
  4. Atkinson, 2004, Mechanism of actin polymerization in cellular ATP depletion., J Biol Chem, 279, 5194, 10.1074/jbc.M306973200 · DOI
  5. Sharfuddin, 2011, Pathophysiology of ischemic acute kidney injury., Nat Rev Nephrol, 7, 189, 10.1038/nrneph.2011.16 · DOI
  6. Puri, 1975, Alterations in energy metabolism and ultrastructure upon reperfusion of the ischemic myocardium after coronary occlusion., Am J Cardiol, 36, 234, 10.1016/0002-9149(75)90532-9 · DOI
  7. Schmiedl, 1990, The surface to volume ratio of mitochondria, a suitable parameter for evaluating mitochondrial swelling. Correlations during the course of myocardial global ischaemia., Virchows Arch A Pathol Anat Histopathol, 416, 305, 10.1007/BF01605291 · DOI
  8. Halestrap, 2010, A pore way to die: The role of mitochondria in reperfusion injury and cardioprotection., Biochem Soc Trans, 38, 841, 10.1042/BST0380841 · DOI
  9. Szeto, 2011, Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury., J Am Soc Nephrol, 22, 1041, 10.1681/ASN.2010080808 · DOI
  10. Hall, 2011, Pores for thought: New strategies to re-energize stressed mitochondria in acute kidney injury., J Am Soc Nephrol, 22, 986, 10.1681/ASN.2011030309 · DOI
  11. Osman, 2011, Making heads or tails of phospholipids in mitochondria., J Cell Biol, 192, 7, 10.1083/jcb.201006159 · DOI
  12. Frey, 2000, The internal structure of mitochondria., Trends Biochem Sci, 25, 319, 10.1016/S0968-0004(00)01609-1 · DOI
  13. Zhang, 2002, Gluing the respiratory chain together. Cardiolipin is required for supercomplex formation in the inner mitochondrial membrane., J Biol Chem, 277, 43553, 10.1074/jbc.C200551200 · DOI
  14. Pfeiffer, 2003, Cardiolipin stabilizes respiratory chain supercomplexes., J Biol Chem, 278, 52873, 10.1074/jbc.M308366200 · DOI · Paper page
  15. Kiebish, 2012, Myocardial regulation of lipidomic flux by cardiolipin synthase: Setting the beat for bioenergetic efficiency., J Biol Chem, 287, 25086, 10.1074/jbc.M112.340521 · DOI
  16. Claypool, 2009, Cardiolipin, a critical determinant of mitochondrial carrier protein assembly and function., Biochim Biophys Acta, 1788, 2059, 10.1016/j.bbamem.2009.04.020 · DOI
  17. Lesnefsky, 2001, Ischemic injury to mitochondrial electron transport in the aging heart: Damage to the iron-sulfur protein subunit of electron transport complex III., Arch Biochem Biophys, 385, 117, 10.1006/abbi.2000.2066 · DOI · Paper page
  18. Lesnefsky, 2009, Enhanced modification of cardiolipin during ischemia in the aged heart., J Mol Cell Cardiol, 46, 1008, 10.1016/j.yjmcc.2009.03.007 · DOI
  19. Vogel, 2006, Dynamic subcompartmentalization of the mitochondrial inner membrane., J Cell Biol, 175, 237, 10.1083/jcb.200605138 · DOI
  20. Ott, 2007, Role of cardiolipin in cytochrome c release from mitochondria., Cell Death Differ, 14, 1243, 10.1038/sj.cdd.4402135 · DOI
  21. Petrosillo, 2004, Ca2+-induced reactive oxygen species production promotes cytochrome c release from rat liver mitochondria via mitochondrial permeability transition (MPT)-dependent and MPT-independent mechanisms: Role of cardiolipin., J Biol Chem, 279, 53103, 10.1074/jbc.M407500200 · DOI
  22. Petrosillo, 2006, Interaction of peroxidized cardiolipin with rat-heart mitochondrial membranes: Induction of permeability transition and cytochrome c release., FEBS Lett, 580, 6311, 10.1016/j.febslet.2006.10.036 · DOI · Paper page
  23. Korytowski, 2011, Permeabilization of the mitochondrial outer membrane by Bax/truncated Bid (tBid) proteins as sensitized by cardiolipin hydroperoxide translocation: Mechanistic implications for the intrinsic pathway of oxidative apoptosis., J Biol Chem, 286, 26334, 10.1074/jbc.M110.188516 · DOI
  24. Belikova, 2006, Peroxidase activity and structural transitions of cytochrome c bound to cardiolipin-containing membranes., Biochemistry, 45, 4998, 10.1021/bi0525573 · DOI · Paper page
  25. Cohen, 2002, Probing protein electrostatics with a synthetic fluorescent amino acid., Science, 296, 1700, 10.1126/science.1069346 · DOI
  26. Leventis, 2010, The distribution and function of phosphatidylserine in cellular membranes., Annu Rev Biophys, 39, 407, 10.1146/annurev.biophys.093008.131234 · DOI · Paper page
  27. Petit, 1992, 10N-nonyl acridine orange interacts with cardiolipin and allows the quantification of this phospholipid in isolated mitochondria., Eur J Biochem, 209, 267, 10.1111/j.1432-1033.1992.tb17285.x · DOI
  28. Paradies, 2009, Role of cardiolipin peroxidation and Ca2+ in mitochondrial dysfunction and disease., Cell Calcium, 45, 643, 10.1016/j.ceca.2009.03.012 · DOI
  29. Vladimirov, 2006, Mechanism of activation of cytochrome C peroxidase activity by cardiolipin., Biochemistry (Mosc, 71, 989, 10.1134/S0006297906090070 · DOI
  30. Sinibaldi, 2010, Extended cardiolipin anchorage to cytochrome c: A model for protein-mitochondrial membrane binding., J Biol Inorg Chem, 15, 689, 10.1007/s00775-010-0636-z · DOI
  31. Sinibaldi, 2008, Insights into cytochrome c-cardiolipin interaction. Role played by ionic strength., Biochemistry, 47, 6928, 10.1021/bi800048v · DOI
  32. Santucci, 1997, The Soret circular dichroism spectrum as a probe for the heme Fe(III)-Met(80) axial bond in horse cytochrome c., J Inorg Biochem, 68, 211, 10.1016/S0162-0134(97)00100-1 · DOI
  33. Zuk, 1998, Polarity, integrin, and extracellular matrix dynamics in the postischemic rat kidney., Am J Physiol, 275, C711, 10.1152/ajpcell.1998.275.3.C711 · DOI
  34. Schwartz, 1999, Ischemia activates actin depolymerizing factor: Role in proximal tubule microvillar actin alterations., Am J Physiol, 276, F544
  35. Cho, 2007, A novel cell-permeable antioxidant peptide, SS31, attenuates ischemic brain injury by down-regulating CD36., J Biol Chem, 282, 4634, 10.1074/jbc.M609388200 · DOI
  36. Kloner, 2012, Reduction of ischemia/reperfusion injury with bendavia, a mitochondria-targeting cytoprotective Peptide., J Am Heart Assoc, 1, e001644, 10.1161/JAHA.112.001644 · DOI
  37. Eirin, 2012, A mitochondrial permeability transition pore inhibitor improves renal outcomes after revascularization in experimental atherosclerotic renal artery stenosis., Hypertension, 60, 1242, 10.1161/HYPERTENSIONAHA.112.199919 · DOI
  38. Smith, 2012, Mitochondrial pharmacology., Trends Pharmacol Sci, 33, 341, 10.1016/j.tips.2012.03.010 · DOI
  39. Chen, 2008, Ischemic defects in the electron transport chain increase the production of reactive oxygen species from isolated rat heart mitochondria., Am J Physiol Cell Physiol, 294, C460, 10.1152/ajpcell.00211.2007 · DOI · Paper page
  40. Borisenko, 2008, Molecular design of new inhibitors of peroxidase activity of cytochrome c/cardiolipin complexes: Fluorescent oxadiazole-derivatized cardiolipin., Biochemistry, 47, 13699, 10.1021/bi801507s · DOI
  41. Kagan, 2009, Mitochondria-targeted disruptors and inhibitors of cytochrome c/cardiolipin peroxidase complexes: A new strategy in anti-apoptotic drug discovery., Mol Nutr Food Res, 53, 104, 10.1002/mnfr.200700402 · DOI
  42. Atkinson, 2011, A mitochondria-targeted inhibitor of cytochrome c peroxidase mitigates radiation-induced death., Nat Commun, 2, 497, 10.1038/ncomms1499 · DOI
  43. Ji, 2012, Lipidomics identifies cardiolipin oxidation as a mitochondrial target for redox therapy of brain injury., Nat Neurosci, 15, 1407, 10.1038/nn.3195 · DOI
  44. Lesnefsky, 2001, Myocardial ischemia selectively depletes cardiolipin in rabbit heart subsarcolemmal mitochondria., Am J Physiol Heart Circ Physiol, 280, H2770, 10.1152/ajpheart.2001.280.6.H2770 · DOI
  45. Paradies, 1999, Lipid peroxidation and alterations to oxidative metabolism in mitochondria isolated from rat heart subjected to ischemia and reperfusion., Free Radic Biol Med, 27, 42, 10.1016/S0891-5849(99)00032-5 · DOI
  46. Lesnefsky, 2004, Ischemia, rather than reperfusion, inhibits respiration through cytochrome oxidase in the isolated, perfused rabbit heart: Role of cardiolipin., Am J Physiol Heart Circ Physiol, 287, H258, 10.1152/ajpheart.00348.2003 · DOI
  47. Kaasik, 2007, Regulation of mitochondrial matrix volume., Am J Physiol Cell Physiol, 292, C157, 10.1152/ajpcell.00272.2006 · DOI
  48. Plotnikov, 2011, Mechanisms of nephroprotective effect of mitochondria-targeted antioxidants under rhabdomyolysis and ischemia/reperfusion., Biochim Biophys Acta, 1812, 77, 10.1016/j.bbadis.2010.09.008 · DOI
  49. Sloan, 2012, Mitochondrial permeability transition in the diabetic heart: Contributions of thiol redox state and mitochondrial calcium to augmented reperfusion injury., J Mol Cell Cardiol, 52, 1009, 10.1016/j.yjmcc.2012.02.009 · DOI
  50. Nitz, 2002, Enantioselective synthesis and application of the highly fluorescent and environment-sensitive amino acid 6-(2-dimethylaminonaphthoyl) alanine (DANA)., Chem Commun (Camb, 17, 1912, 10.1039/b205224e · DOI
  51. Chen, 2006, Syntheses of aladan and [ald6]ioloatin C and study on their fluorescent properties., Chin J Chem, 24, 1411, 10.1002/cjoc.200690264 · DOI

Cited by

Sorted by citations

Metadata

Authors
Birk, A. V., Liu, S., Soong, Y., Mills, W., Singh, P., Warren, J. D., Seshan, S. V., Pardee, J. D., & Szeto, H. H.
Venue
Journal of the American Society of Nephrology
Published
2013-08
Volume
24
Issue
8
Pages
1250-1261
ISSN
1046-6673
Cited by
479
References
10
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review